Nevro Executive Compensation (FY23)

Name: Nevro (NVRO) executive compensation
Creator: Velarion
License: https://intel.velarion.ai/terms

NVRO · Executive and director compensation, fiscal 2022 to 2023

Chief executive, fiscal 2023

◇

Kevin Thornal

Median of the other named officers

$2,577,179

5 officers, excluding the chief executive

Latest say-on-pay support

May 23, 2024

Velarion Intel, $5,000/year: one seat · one year · every company we cover, with dashboards, peer screens and board-ready briefs.

See every company’s exec pay — free for 3 days, no card See the plan and pricing

The paid brief on Nevro

Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.

$500 for the Executive Compensation Report. Both reports for $900.

Get the executive brief Get the board briefNo account needed.

Data as of November 5, 2026Latest filing (8-K): May 29, 2024

9 filings cited on this page

Method: intel.velarion.ai/methodology

A report that fails to generate is refunded in full

Published by Velarion Company Intelligence

Nevro brief$500Get the executive brief

Velarion Intel, one year, every company

202 figures on this page: 194 cited to the filing that reported them, 8 calculated from figures it prints. See the citations

Frequently asked questions

Answers drawn from the data on this page.

Who is Nevro's chief executive and what were they paid?

Kevin Thornal, President and Chief Executive Officer, received $11,453,548 in total compensation for fiscal 2023.

What was Nevro's say-on-pay result?

Shareholders recorded 95.2% support for the say-on-pay proposal at the meeting held May 23, 2024 for fiscal 2023.

Which companies are in Nevro's peer group?

Companies named in the disclosed peer group include Alphatec Holdings, AngioDynamics, AtriCure, Axonics and Cardiovascular Systems, among others.

Executive compensation

Every element reported for each named executive officer, by fiscal year.

Fiscal 2022

Officer	Salary	Bonus	Stock awards	Option awards	Non-equity incentive	Pension and deferred earnings	All other compensation	Total
D. Keith Grossman Chairman, Former President and Chief Executive Officer	◇	—	◇	—	◇	—	◇	◇
Niamh Pellegrini Former Senior Vice President and Chief Commercial Officer	◇	—	◇	—	◇	—	◇	◇
Kashif Rashid Senior Vice President, Corporate Development and Chief Legal Officer	◇	—	◇	—	◇	—	◇	◇
Roderick MacLeod Senior Vice President and Chief Financial Officer	◇	—	◇	—	◇	—	◇	◇

Fiscal 2023

Officer	Salary	Bonus	Stock awards	Option awards	Non-equity incentive	Pension and deferred earnings	All other compensation	Total
Kevin Thornal President and Chief Executive Officer	◇	—	◇	—	◇	—	◇	◇
Niamh Pellegrini Former Senior Vice President and Chief Commercial Officer Departed during or after this year	◇	—	◇	—	—	—	◇	◇
Greg Siller Senior Vice President and Chief Commercial Officer	◇	—	◇	—	◇	—	◇	◇
Roderick MacLeod Senior Vice President and Chief Financial Officer	◇	—	◇	—	◇	—	◇	◇
Kashif Rashid Senior Vice President, Corporate Development and Chief Legal Officer	◇	—	◇	—	◇	—	◇	◇
D. Keith Grossman Chairman, Former President and Chief Executive Officer Departed during or after this year	◇	—	◇	—	—	—	◇	◇

A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. A negative change in pension value is shown but, as the company reports it, not included in the total.

Equity awards granted

Individual awards as disclosed: type, date, unit counts at each level, and grant date value.

Fiscal 2023

Officer	Award	Grant date	Threshold units	Target units	Units granted	Maximum units	Exercise price	Grant date fair value
D. Keith Grossman	RSU	◇	—	—	◇	—	—	◇
Greg Siller	RSU	◇	—	—	◇	—	—	◇
Greg Siller	PSU	◇	◇	◇	—	◇	—	◇
Kashif Rashid	PSU	◇	◇	◇	—	◇	—	◇
Kashif Rashid	RSU	◇	—	—	◇	—	—	◇
Kevin Thornal	PSU	◇	◇	◇	—	◇	—	◇
Kevin Thornal	RSU	◇	—	—	◇	—	—	◇
Niamh Pellegrini	PSU	◇	◇	◇	—	◇	—	◇
Niamh Pellegrini	RSU	◇	—	—	◇	—	—	◇
Roderick H. MacLeod	PSU	◇	◇	◇	—	◇	—	◇
Roderick H. MacLeod	RSU	◇	—	—	◇	—	—	◇

A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. Threshold, target and maximum apply only to performance awards and are never shown for time-based or option awards.

Outstanding awards

Awards still held at fiscal year end.

As disclosed at fiscal 2023 year end

Officer	Award	Unvested units	Market value of unvested units	Exercise price	Expires
Kevin Thornal	RSU	◇	◇	—	—
	PSU	◇	◇	—	—
Greg Siller	RSU	◇	◇	—	—
	PSU	◇	◇	—	—
D. Keith Grossman	PSU	◇	◇	—	—
	RSU	◇	◇	—	—
	RSU	◇	◇	—	—
	RSU	◇	◇	—	—
	PSU	◇	◇	—	—
Kashif Rashid	RSU	◇	◇	—	—
	PSU	◇	◇	—	—
	RSU	◇	◇	—	—
	RSU	◇	◇	—	—
	RSU	◇	◇	—	—
	RSU	◇	◇	—	—
	PSU	◇	◇	—	—
Roderick MacLeod	RSU	◇	◇	—	—
	PSU	◇	◇	—	—
	RSU	◇	◇	—	—
	RSU	◇	◇	—	—
	RSU	◇	◇	—	—
	PSU	◇	◇	—	—

A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Director compensation

What each non-employee director was paid.

Fiscal 2023

Director	Fees earned in cash	Stock awards	Option awards	Non-equity incentive	Pension and deferred earnings	All other compensation	Total
Michael DeMane Lead independent director	◇	◇	—	—	—	—	◇
Kevin O'Boyle	◇	◇	—	—	—	—	◇
Elizabeth Weatherman	◇	◇	—	—	—	—	◇
Karen Prange	◇	◇	—	—	—	—	◇
Shawn T McCormick	◇	◇	—	—	—	—	◇
Frank Fischer	◇	◇	—	—	—	—	◇
Sri Kosaraju	◇	◇	—	—	—	—	◇
Susan Siegel	◇	◇	—	—	—	—	◇

Kevin Thornal, D. Keith Grossman and Kirt P. Karros served on the board in fiscal 2023 and received no compensation for board service. Executive directors are typically paid through their executive roles, shown above.

A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Director fee schedule

The standing retainers and premiums the board pays, as published.

Board cash retainer	◇
Board equity retainer	◇
Total board retainer	◇
Board chair premium	◇
Lead independent director premium	◇
Audit committee chair	◇
Audit committee member	◇
Compensation committee chair	◇
Compensation committee member	◇
Nominating and governance chair	◇
Nominating and governance member	◇

Equity is delivered as restricted stock units.

Disclosed peer group

The companies this board named as its compensation comparison group. The list is disclosure; the comparison is analysis.

Fiscal 2023

Alphatec Holdings ATEC
AngioDynamics ANGO
AtriCure ATRC
Axonics AXNX
Cardiovascular Systems CSII
Glaukos GKOS
Globus Medical GMED
Haemonetics HAE
Integra LifeSciences IART
iRhythm Technologies IRTC
Masimo MASI
Natera NTRA
NovoCure NVCR
NuVasive NUVA
Orthofix Medical OFIX
Penumbra PEN
Tandem Diabetes Care TNDM

Say-on-pay history

Shareholder support for the compensation program, by year.

Year	Meeting	Support	Votes for	Votes against	Abstentions
2023	May 23, 2024	=	◇	◇	◇
2022	May 25, 2023	=	◇	◇	◇
2021	May 26, 2022	=	◇	◇	◇
2020	May 25, 2021	=	◇	◇	◇
2019	May 21, 2020	=	◇	◇	◇
2018	May 20, 2019	=	◇	◇	◇
2017	May 21, 2018	=	◇	◇	◇
2016	May 25, 2017	=	◇	◇	◇

Ask our research desk — $99, 24h, every figure cited to its filing.

Sample answer — “What is the CEO’s total compensation?”

- Kevin Thornal (President and Chief Executive Officer), FY2023 total compensation $11,453,548 (base salary $515,625) [exec_comp, SEC accession 0000950170-24-044100, filed 2024-04-12]

See a complete sample report

What this page does not include

Everything above is a fact Nevro disclosed, and it is free. Everything below is our analysis of those facts, and it is not.

Peer benchmarking

Where Nevro sits against its disclosed peers — percentile position by role and by pay element, and the ranking behind it. The disclosed peer group is free; comparisons across it are part of the Velarion platform.

Executive Compensation Report — $500

Written compensation analysis

A read of the pay program as designed and as paid: incentive structure, goal rigor, the alignment between the committee's stated philosophy and what the numbers show.

Executive Compensation Report — $500

Board and governance analysis

Committee composition, independence, director pay positioning, and the governance provisions read together rather than listed.

Board Governance Report — $500

Realizable pay

What the awards above are actually worth today against what they were valued at on grant, and what the gap says about the pay-for-performance link.

Velarion Intelligence

Adviser switching and vote outcomes

Two datasets covering compensation-adviser changes and what followed a contested vote. Both are part of the Velarion platform.

Inquire about access

Multiple companies at once

Cross-company views, cohort screens, and data export across the industries we cover. This page is one company; the platform is all of them.

Velarion Intelligence

Citations

Every figure on this page is cited to the document that reported it. Select any figure to see its citation.

202 figures on this page: 194 cited to the filing that reported them, 8 calculated from figures it prints.

194 cited to the filing

8 calculated from the filing

Documents cited

8-K, filed May 29, 2024
0000950170-24-065955
Proposal 3 . The approval, on a non-binding, advisory basis, of the compensation of the Company’s named executive officers: Votes For Votes Against Abstentions Broker Non-Votes
DEF 14A, filed April 12, 2024
0000950170-24-044100
2023 Grants of Plan-Based Awards · DIRECTOR COMPENSATION · EXECUTIVE COMPENSATION TABLES · Grants of Plan-Based Awards
8-K, filed May 30, 2023
0000950170-23-024932
Proposal 3 . The approval, on a non-binding, advisory basis, of the compensation of the Company’s named executive officers: Votes For Votes Against Abstentions Broker Non-Votes
8-K, filed May 31, 2022
0001564590-22-021914
Item 5.07 Submission of Matters to a Vote of Security Holders.
8-K, filed May 28, 2021
0001564590-21-030841
Item 5.07 Submission of Matters to a Vote of Security Holders.
8-K, filed May 26, 2020
0001564590-20-026875
Proposal 3
8-K, filed May 24, 2019
0001564590-19-020480
Item 5.07 Submission of Matters to a Vote of Security Holders
8-K, filed May 25, 2018
0001564590-18-014436
Item 5.07 Submission of Matters to a Vote of Security Holders
8-K, filed May 31, 2017
0001564590-17-011947
Item 5.07 Submission of Matters to a Vote of Security Holders

Cite this data

This page is free to cite. Attribution we ask for:

Velarion, “Nevro executive compensation, FY2022–FY2023.” https://intel.velarion.ai/comp/NVRO (accessed 2026).

Short form: data: Velarion

The paid brief for Nevro

Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.

$500 for the Executive Compensation Report. Both reports for $900.

Get the executive brief Get the board briefNo account needed.

9 filings cited on this page

Method: intel.velarion.ai/methodology

A report that fails to generate is refunded in full

Published by Velarion Company Intelligence

Embed this data

A small, cited view of this data for your own page or newsletter. Every embed carries a visible link back here, so the attribution travels with it.

The headline figures, each with its citation.

<iframe src="https://intel.velarion.ai/comp/NVRO/embed" width="560" height="480" style="border:1px solid #d8dee8;border-radius:10px" loading="lazy" title="Nevro executive compensation, from Velarion"></iframe>

Connect an AI assistant

Ask your own assistant about Nevro and roughly 3,000 other US public companies, and get back the same figures on this page with the same citations. Free read access, no account. Add this to your assistant's connector settings.

{
  "mcpServers": {
    "velarion": {
      "type": "http",
      "url": "https://api.velarion.ai/mcp"
    }
  }
}

Setup guide and the full list of questions it answers

Peers Nevro discloses

The companies named in NVRO's own disclosed peer group.

Alphatec Holdings AngioDynamics AtriCure Glaukos Globus Medical Haemonetics Integra LifeSciences iRhythm Technologies Masimo Natera NovoCure NuVasive Orthofix Medical Penumbra Tandem Diabetes Care

Terms on this page

Say-on-Pay Vote CEO Pay Ratio Median Employee Compensation All companies

Free to read and cite. Redistribution or bulk use of the dataset requires a data license. Talk to us about the data license.

Cite this data

APA

Velarion Company Intelligence. (2026). Velarion database: executive and board compensation data (Version 2026Q3) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.22283854

BibTeX

@misc{velarionData2026,
  author = {{Velarion Company Intelligence}},
  title = {Velarion database: executive and board compensation data},
  year = {2026},
  version = {2026Q3},
  doi = {10.5281/zenodo.22283854},
  publisher = {Zenodo},
  url = {https://doi.org/10.5281/zenodo.22283854}
}

More on Nevro

Frequently asked questions

Executive compensation

Equity awards granted

Outstanding awards

Director compensation

Director fee schedule

Disclosed peer group

Say-on-pay history

What this page does not include

Citations

Documents cited

The paid brief for Nevro

Peers Nevro discloses

Terms on this page